has turned to an outsider in its search for a new chief
executive, naming top US healthcare industry executive
Peter Loescher, 49, head of global human health at Merck
since April 2006.
who replaces outgoing CEO and president Klaus Kleinfeld
will step down on 30 June to pave the way for Loescher
to assume charge on 1 July, Siemens said in a statement.
statement says Loescher gained management experience
at General Electric, where he headed the GE healthcare
biosciences division as well as at Amersham, Aventis
Pharma and Hoechst,.
is said to have preferred an external candidate to ensure
a new chief executive would not be drawn into ongoing
investigations into bribery allegations, though Kleinfeld
himself is not accused of corruption in the investigations.
has been facing investigations by German and US authorities
in several separate cases of suspected bribery involving
hundreds of millions of euros.